Inventor · disambiguated record
Sarah Robertson
Also filed as: ROBERTSON SARAH · ROBERTSON SARAH M · ROBERTSON SARAH MARIE
7 granted patents·6 pending applications·74 citations·filing 2016–2024
85Inventor score
Files withVERTEX PHARMA13
Top patents by PatentIndex Score
13 records- 0194US11155533B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Oct 26, 2021·10 cites·13 claims
- 0293US10654829B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2018·Granted May 19, 2020·21 cites·23 claims
- 0392US11517564B2Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2018·Granted Dec 6, 2022·8 cites·26 claims
- 0492US11179367B2Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2019·Granted Nov 23, 2021·18 cites·13 claims
- 0588US11253509B2Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2018·Granted Feb 22, 2022·9 cites·21 claims
- 0686US9771361B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Sep 26, 2017·8 cites·48 claims
- 0777US2025099425A1Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0874US12350262B2Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2022·Granted Jul 8, 2025·0 cites·4 claims
- 0966US2022257564A1Pharmaceutical compositions for treating cystic fibrosisVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1053US2022047564A1Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 1147US2020171015A1Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1246US2020054633A1Combination therapies for treating influenza virus infectionVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 1345US2021069174A1Compositions and methods for treatment of cystic fibrosisVERTEX PHARMA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sarah Robertson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →